醛固酮肾素比值筛查原发性醛固酮增多症的性能评价
系统检索MEDLINE、Embase和Cochrane数据库至2020年2月,纳入10项观察性研究共4110名参与者,评估醛固酮肾素比值(ARR)筛查原发性醛固酮增多症的诊断性能。ARR灵敏度范围10%至100%,特异度70%至100%,3项研究报告灵敏度<50%,因人群和诊断标准异质性大,无法推荐统一ARR阈值。
要点
- ARR筛查原发性醛固酮增多症的灵敏度波动大(10%-100%),部分研究灵敏度<50%。
- 特异度范围为70%-100%,但研究间诊断标准与实验室检测差异显著。
- 因异质性无法确定统一ARR阳性阈值,临床决策需认识其准确性局限。
核心结论
- ARR筛查性能随人群和诊断标准变化大,尤其灵敏度不稳定,无法推荐单一阈值。
- 临床需认识ARR准确性和可靠性局限以合理决策。
研究设计与样本
- 系统检索MEDLINE、Embase和Cochrane数据库至2020年2月,纳入评估ARR筛查诊断性能的观察性研究。
- 为减少验证偏倚,仅纳入无论ARR结果均行动态确证试验作为参考标准的研究。
- 共纳入10项研究,总计4110名参与者,使用QUADAS-2工具评估偏倚风险与适用性。
主要发现
- ARR灵敏度范围10%至100%,特异度范围70%至100%。
- 10项研究中3项报告ARR灵敏度<50%,提示识别原发性醛固酮增多症能力有限。
- 研究间人群基础、ARR阳性阈值、实验室检测和确证试验参考标准差异显著。
- 半数研究存在与患者选择相关的潜在偏倚风险。
关键数值与推荐
- ARR灵敏度最低10%、最高100%;特异度最低70%、最高100%。
- 3/10项研究报告ARR灵敏度<50%。
临床怎么用
- ARR作为指南推荐的筛查试验,临床解读需结合人群和本地诊断标准,不宜套用统一阈值。
- 对ARR阴性但临床高度怀疑原发性醛固酮增多症者,应考虑其灵敏度局限。
局限性
- 纳入研究间患者选择、ARR阈值、实验室检测和参考标准异质性大。
- 半数研究存在患者选择偏倚风险,可能影响诊断性能评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The aldosterone to renin ratio (ARR) is the guideline-recommended screening test for primary aldosteronism. However, there are limited data in regard to the diagnostic performance of the ARR. OBJECTIVE: To evaluate the sensitivity and specificity of the ARR as a screening test for primary aldosteronism. METHODS: We searched the MEDLINE, Embase, and Cochrane databases until February 2020. Observational studies assessing ARR diagnostic performance as a screening test for primary aldosteronism were selected. To limit verification bias, only studies where dynamic confirmatory testing was implemented as a reference standard regardless of the ARR result were included. Study-level data were extracted and risk of bias and applicability were assessed using the QUADAS-2 tool. RESULTS: Ten studies, involving a total of 4110 participants, were included. Potential risk of bias related to patient selection was common and present in half of the included studies. The population base, ARR positivity threshold, laboratory assay, and reference standard for confirmatory testing varied substantially between studies. The reported ARR sensitivity and specificity varied widely with sensitivity ranging from 10% to 100% and specificity ranging from 70% to 100%. Notably, 3 of the 10 studies reported an ARR sensitivity of <50%, suggesting a limited ability of the ARR to adequately identify patients with primary aldosteronism. CONCLUSIONS: ARR performance varied widely based on patient population and diagnostic criteria, especially with respect to sensitivity. Therefore, no single ARR threshold for interpretation could be recommended. Limitations in accuracy and reliability of the ARR must be recognized in order to appropriately inform clinical decision-making.
引用
- Hung A, Ahmed S, Gupta A, et al. Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism. J Clin Endocrinol Metab. 2021. PMID: 34008000. doi:10.1210/clinem/dgab348
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。